The efficacy and safety of estriol to treat vulvovaginal atrophy in postmenopausal women: a systematic literature review.

CONCLUSIONS: The available evidence (of low and moderate quality) shows that, when administered vaginally, estriol preparations appear to be safe for women who have risk factors related to systemic estrogen therapy.
PMID: 28622049 [PubMed - as supplied by publisher]

Source: Climacteric - June 16, 2017 Category: Geriatrics Authors: Rueda C, Osorio AM, Avellaneda AC, Pinzón CE, Restrepo OI Tags: Climacteric Source Type: research